Response to Comments: Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms

This document is a response-to-comments notice for the LCD on Genomic Sequence Analysis Panels for solid organ neoplasms and does not state clinical coverage criteria. It records that the public comment period was solicited and that the official notice began February 10, 2022, with the final determination effective April 1, 2022; refer to the final LCD for specific coverage, limitations, and documentation requirements.

"Official notice period for the final LCD begins on 2022-02-10 and the final determination becomes effective on 2022-04-01."

Sign up to see full coverage criteria, indications, and limitations.